HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
South Korea
10-2022-7031589
Filed on 2022-09-13
10-2022-7031589
Filed on 2022-09-13
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Japan
2022-549088
Filed on 2022-08-12
2022-549088
Filed on 2022-08-12
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
India
202247050807
Filed on 2022-09-06
202247050807
Filed on 2022-09-06
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
European Patent
21710740.8
Filed on 2022-09-13
21710740.8
Filed on 2022-09-13
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
China
202180014281.4
Filed on 2022-08-12
202180014281.4
Filed on 2022-08-12
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Canada
3167382
Filed on 2022-08-09
3167382
Filed on 2022-08-09
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Australia
2021220957
Filed on 2022-08-04
2021220957
Filed on 2022-08-04
PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY
South Korea
10-2022-7023239
Filed on 2022-07-06
10-2022-7023239
Filed on 2022-07-06
PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY
European Patent
20899103.4
Filed on 2020-12-11
20899103.4
Filed on 2020-12-11
PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY
Australia
2020403013
Filed on 2020-12-11
2020403013
Filed on 2020-12-11